OzarslanBRussoTArgenzianoGSantoroCPiccoloV. Cutaneous findings in neurofibromatosis type 1. Cancers (Basel). 2021;13(3):463. doi:10.3390/cancers13030463
2.
VirdisRStreetMEBandelloMA, et al. Growth and pubertal disorders in neurofibromatosis type 1. J Pediatr Endocrinol Metab. 2003;16(Suppl 2):289-292.
3.
MoherDLiberatiATetzlaffJAltmanDG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. doi:10.1136/bmj.b2535
4.
MunnZAromatarisETufanaruC, et al. The development of software to support multiple systematic review types: the Joanna Briggs Institute System for the Unified Management, Assessment and Review of Information (JBI SUMARI). Int J Evid Based Healthc. 2019;17(1):36-43. doi:10.1097/XEB.0000000000000152
5.
MunnZBarkerTHMoolaS, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth. 2020;18(10):2127-2133. doi:10.11124/JBISRIR-D-19-00099
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
